xucx Wahab Riaz targets repeat of World Cup performance

Deoj Sindh Assembly passes bill against forced religious conversions
KARACHI:The Supreme Court (SC) expressed on Friday its extreme displeasure at the poor state of administration in Sindh, observing that billions of rupees were going 'here and there' but on the ground no work was being done."Of Rs100, Rs90 go here and there and only Rs adidas samba 10 are spent," remarked Justice Gulzar Ahmed, who headed a two-judge bench hearing a suo motu case regarding contamination of water in the Manchar Lake.The judge remarked that work can be done if at least 60% of the allocated funds are utilised. His remarks came after the irrigation department's secretary admitte adidas samba hombre d that two reverse osmosis plants installed to supply clean drinking water to the residents of the fishermen settlement near the Manchar Lake were lying non-functional.The deputy attorney-general informed the court that the federal and provincial governments had agreed on completing the remaining portion of nb 550 the Right Bank Outfall Drain (RBOD) I, II and III projects.The provincial irrigation secretary informed the Weill Cornell Medical College investigators tried to validate a previously reported molecular finding on triple negative breast cancer that many hoped would lead to targeted treatments for the aggressive disease. Instead, they discovere yeezy d that the findings were limited to a single patient and could not be applied to further clinical work. This discovery, publish adidas yeezy ed April 15 in Nature, amends the earlier work and underscores the importance of independent study validation and careful assay development.The earlier 鈥?and now dispelled 鈥?study, published in Nature in June nike dunk sb 2012 by researchers at the Broad Institute of MIT and Harvard, found a gene fusion in a small but significant number of tumor samples from patients with triple negative breast cancer, a particularly deadly subtype that often has few treatment options. The original research team concluded that MAGI3-AKT3 fusion could offer a new molecular target to use for drug development.Soon after this study was published, a Weill Cornell